Risk of Cardiovascular Events Associated with Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis
Background. The cardiovascular (CV) safety of inhaled corticosteroids (ICSs) in chronic obstructive pulmonary disease (COPD) is controversial because different studies have suggested that ICSs either increase or reduce the risk of CV events in COPD patients. In this meta-analysis, we assess the CV s...
Saved in:
| Main Authors: | Xia Jing, Yufeng Li, Jianying Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2018/7097540 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose of Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease and Risks of Osteoporosis or Fracture—A Systematic Review and Meta‐Analysis
by: Wang Chun Kwok, et al.
Published: (2025-05-01) -
Inhaled Corticosteroids Should Not Be Prescribed to All Chronic Obstructive Pulmonary Disease Patients
by: Jean Bourbeau, et al.
Published: (2003-01-01) -
Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
by: Elvis M. Irusen, et al.
Published: (2020-12-01) -
Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Fathur Nur Kholis, et al.
Published: (2023-01-01) -
Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-12-01)